Search clinical trials for: hepatic decompensation

Total 5965 results

Seoul National University Hospital

Recruiting

Ate-Bev Early Response Prediction Model in Advanced HCC

Hepatocellular Carcinoma | Atezolizumab-bevacizumab | Response Evaluation

Korea, Republic of
Shanghai Zhongshan Hospital

Not yet recruiting

Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

Posto Perative Hepatocellular Carcinoma
Cairo University

Recruiting

Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
National Taiwan University Hospital

Not yet recruiting

A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma

Hepatocellular Carcinoma | Radiotherapy | Biomarker | Hepatitis b Virus
Fudan University

Recruiting

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Colorectal Liver Metastasis

China
Sun Yat-sen University

Recruiting

TACE-HAIC Plus Atezolizumab and Bevacizumab for Unresectable HCC: a Phase 2 Clinical Trial

Hepatocellular Carcinoma

China
AstraZeneca

Recruiting

Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment

Hepatic Impairment

United States
RenJi Hospital
The Affiliated Hospital of Qingdao University; The First Affiliated Hospital...

Not yet recruiting

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)

Liver Transplant Disorder | Hepatic Cancer | End-stage Liver Disease
Medical University of Vienna

Recruiting

FMT in IT-refractory HCC - FAB-HCC Pilot Study

Hepatocellular Carcinoma

Austria
WhiteSwell, Limited

Recruiting

The Safety and Feasibility of the eLym™ System (DELTA-HF)

Heart; Decompensation, Congestive

Spain, Georgia, Poland
Jagiellonian University

Recruiting

Lesser Poland Cracovian Heart Failure Registry (LECRA-HF)

Heart Failure | Heart Failure Acute

Poland
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Diabetes Mellitus, Type 2

Korea, Republic of
Chiesi Hungary Ltd.
Chiesi Slovenija, d.o.o.

Recruiting

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients (LTA)

Liver Failure

Hungary, Slovenia
Erasmus Medical Center
Rijndam Revalidatiecentrum; Capri Hartrevalidatie

Recruiting

PREoPerAtive pREhabilitation in Patients With Head and Neck Cancer or Liver Cancer (PREPARE) (PREPARE)

Cancer Head Neck | Cancer Liver

Netherlands
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Academisch...

Recruiting

Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes

Insulin Resistance | Hypertriglyceridemia

Netherlands
M.D. Anderson Cancer Center
TriSalus Life Sciences

Recruiting

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Liver Cancer

United States
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Registry Study for Optimal Management of Liver Failure in the Chinese Population (RESOLVE-C)

Liver Failure

China
Sohag University

Not yet recruiting

Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic Patients

Hepatocellular Carcinoma

Egypt
West China Hospital

Recruiting

Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

China
Beijing Hospital

Recruiting

Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3

Hepatocellular Carcinoma

China
Wen Tianfu

Recruiting

Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)

Advanced Hepatocellular Carcinoma

China
Replimune Inc.
Roche Pharma AG

Not yet recruiting

RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC

Recurrent Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma

United States, United Kingdom, France, Germany, Greece
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Renal Impairment | Hepatic Impairment

China
Imperial College London

Not yet recruiting

FibroLamellar Carcinoma: an International Registry Study (FLiCIR)

Fibrolamellar Cancer of the Liver
Seoul National University Hospital

Recruiting

Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC

Hepatocellular Carcinoma | Malignant Biliary Obstruction

Korea, Republic of
Abramson Cancer Center at Penn Medicine

Recruiting

QOL and Sarcopenia in Patients With Ascites

Ascites Hepatic | Ascites, Malignant

United States
RenJi Hospital
Shanghai Institute of Biochemistry and Cell Biology

Not yet recruiting

Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults

Acute-On-Chronic Liver Failure | Chronic Liver Failure
University of Kansas Medical Center
Varian Medical Systems

Recruiting

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC (vGRID SBRT)

Liver Cancer

United States
Sun Yat-sen University

Recruiting

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Colorectal Cancer Metastatic

China
Amsterdam UMC, location VUmc
UMC Utrecht; General Hospital Groeninge; Intuitive Surgical; Fondazione Poliambulanza...

Not yet recruiting

Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT) (LIVEROBOT)

Liver Diseases | Biliary Tract Diseases | Liver Metastases | Liver Neoplasm | Biliary Tract Neoplasms | Liver Cancer | Biliary Tract Cancer
University of Texas Southwestern Medical Center
Cancer Prevention Research Institute of Texas; Arcus Biosciences, Inc.

Recruiting

Domvanalimab and Zimberelimab in Advanced Liver Cancers

Hepatocellular Carcinoma | Cholangiocarcinoma | Liver Cancer | Hepatobiliary Cancer

United States
Yale University
Boehringer Ingelheim

Recruiting

Empagliflozin in Patients With Cirrhosis and Ascites (EMPA Liver)

Liver Failure | Cirrhosis

United States
Atea Pharmaceuticals, Inc.

Recruiting

Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

Hepatic Impairment | Healthy Volunteer

United States
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

Hepatocellular Carcinoma | Chronic Hepatitis B

China
Nanfang Hospital of Southern Medical University

Recruiting

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer

Liver Cirrhosis | Hepatitis | Fatty Liver | Liver Cancer

China
KU Leuven
Jules Bordet Institute; Erasme University Hospital; GZA Ziekenhuizen Campus Sint-Augustinus

Not yet recruiting

Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues. (OLiver Pro)

Breast Cancer | Liver Metastases

Belgium
Liaoning Tumor Hospital & Institute

Not yet recruiting

Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
Universidade Federal do Rio de Janeiro

Not yet recruiting

Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder

Portal Hypertension | Idiopathic Non-Cirrhotic Portal Hypertension | Non-Cirrhotic Portal Hypertension | Vascular Disorder of Liver | Non-Cirrhotic Portal Fibrosis | Regenerative Nodular Hyperplasia | Incomplete Septal Cirrhosis | Obliterative Portal Venopathy | Hepatoportal Sclerosis | Idiopathic Portal...

Brazil
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Liver Cancer

United States
Postgraduate Institute of Medical Education and...
Indian Council of Medical Research

Recruiting

Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients

Hepatocellular Carcinoma

India
RenJi Hospital

Recruiting

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Hepatocellular Carcinoma | Liver Cancer | Resistant Cancer

China
Sun Yat-sen University

Not yet recruiting

SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH) (SEARCH)

Advanced Hepatocellular Carcinoma

China
Ruijin Hospital

Not yet recruiting

Albumin Infusion in Inpatients With Decompensated Cirrhosis

Decompensated Cirrhosis | Acute-On-Chronic Liver Failure

China
Sun Yat-sen University

Recruiting

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Hepatocellular Carcinoma

China
Tongji Hospital
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma (CCGLC-008)

Hepatocellular Carcinoma Non-resectable

China
Wan-Guang Zhang
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma (CCGLC-001)

Hepatocellular Carcinoma Non-resectable

China
IRCCS San Raffaele

Recruiting

Liver Embolization Approaches for Tumor Management (LEATUM)

Hepatocellular Carcinoma | Metastatic Cancer | Primary Liver Cancer | Cholangiocarcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer | Metastatic Colon Cancer

Italy
Nanjing Zenshine Pharmaceuticals

Recruiting

Pharmacokinetic Characteristics of Subjects With Hepatic Insufficiency and Healthy Subjects

Influenza, Human

China
Guangxi Medical University

Not yet recruiting

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University
Yiwu Central Hospital; Zhejiang Provincial Tongde Hospital

Not yet recruiting

A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver Cancer

Liver Cancer

China

Search clinical trials for: hepatic decompensation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations